Where does Hemanext's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Hemanext's 6 recorded funding rounds.

Premier Alternatives

Hemanext

Lexington, MA · Founded 2000 · Privately Held (backing)

Developer of transfusion medical technology designed to support the transfusion medicine community in efforts to save lives and improve patient outcomes. Hemanext is based in Lexington, MA and was founded in 2000. Its last reported valuation was $115 million in Oct 2024. It has raised $220 million across 6 recorded rounds; the latest was a $20 million early-stage round in Jul 2025.

Last reported valuation

$115.0M

Oct 2026

Priced at

—

Total raised

$220.3M

Last round

Early Stage VC

Jul 2025

Cap table — not yet on record

Hemanext's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Hemanext with a free account

·The complete investor list: 12 names
·Watch Hemanext: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Hemanext

Where does Hemanext's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Hemanext's 6 recorded funding rounds.